Where is Novartis?, page-110

Thanks for your response old bean.

First, I can’t imagine any country would be forking out $35k a pop for something like stems which are marginal at best. There are cheaper alternatives now and more will be fast tracked. That’s why no one is talking about stems as a treatment.

Second, not sure how India is relevant if you say it Isn’t a target. Although I do agree there are very wealthy people there who would pay. Perhaps mesoblast will need to market to them in their 7 star hotels.

third, you must be that fly on the wall looking down at all these negotiations. Can you tell me what you see now? Are they still signing the contract?

Fourth, it is certainly novel to say that mesoblast is good at getting things approved. That would be an incredible surprise to the FDA.

Finally, I’m happy with hole or bunker. If it makes you happy old bean then I feel I have achieved something.. perhaps suggest finger fatigue to SI …he’d be in on that I recon … another potential treatment to tout but never achieved.